Polymyositis

Type: Keyphrase
Name: Polymyositis
First reported Jul 25 2014 - Updated Jul 25 2014 - 1 reports

Questcor (QCOR) Misses on Q2 Earnings, Beats on Revenues

Questcor Pharmaceuticals Inc. ( QCOR ) reported second quarter 2014 earnings per share of $1.71, up from the year-ago earnings of $1.25 per share. Excluding share- based compensation expense, one-time items and non-cash expenses, earnings stood at $1.85 ... [Published Yahoo! Finance - Jul 25 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

Questcor Reports Record Second Quarter Financial Results

/PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) today reported financial results for the second quarter ended June 30, 2014.Net sales for the second quarter ended June 30, 2014 were $278.8 million, up 51% from $184.6 million in GAAP net sales ... [Published Nasdaq - Jul 24 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

Bristol-Myers Squibb and Ono Pharmaceutical Co., -2-

Immune-mediated Enterocolitis:-- In the pivotal Phase 3 study in Yervoy-treated patients, severe,life-threatening, or fatal (diarrhea of =7 stools above baseline, fever,ileus, peritoneal signs; Grade 3-5) immune-mediated enterocolitisoccurred in 34 (7%) ... [Published Scottrade - Jul 24 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

Patent Issued for Aminopyridine- and Aminopyrimidinecarboxamides as CXCR2 Modulators

By a News Reporter-Staff News Editor at Biotech Week -- A patent by the inventors Maeda , Dean Y. ( Seattle, WA ); Zebala, John A. ( Issaquah, WA ); Schuler, Aaron D. ( Auburn, WA ), filed on August 22, 2011 , was published online on July 15, 2014 , according ... [Published 4 Traders - Jul 24 2014]
First reported Jul 21 2014 - Updated Jul 21 2014 - 1 reports

Patients urged to 'partner' with caregivers

When Sarah Head first came to Emory University Midtown Hospital in 2010, she felt like her health was falling apart.She says, "I went from stumbling, to walking with a cane, to not walking at all."The Atlanta native, who’d moved to rural Tuskegee, Alabama, ... [Published Fox 5 Atlanta WAGA - Jul 21 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 1 reports

Neck pain, back pain, shoulder pain, arm…

Acupuncture/ Pain Management Clinic/Neurologist in Stony Brook offering evening and Saturday hours! Dr Michael Guo is board certified in Pain Management, Neurology and also a licensed Acupunctural physician!If you are among the 50 million Americans living ... [Published Sachem Patch - Jul 10 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 1 reports

Mason Smedley continues to inspire in partnership of Cure JM and Intel

For the first year of his life, Mason Smedley was apparently healthy. A blond-haired boy with bright blue eyes, he was growing into his childhood in a way that seemed normal to his parents. But as he edged closer to a year and a half, they started noticing ... [Published Oregonian - Jul 09 2014]
First reported Jul 03 2014 - Updated Jul 03 2014 - 1 reports

Neck pain, back pain, shoulder pain, arm…

Acupuncture/ Pain Management Clinic/Neurologist in Stony Brook offering evening and Saturday hours! Dr Michael Guo is board certified in Pain Management, Neurology and also a licensed Acupunctural physician!If you are among the 50 million Americans living ... [Published Five Towns Patch - Jul 03 2014]
First reported Jun 26 2014 - Updated Jun 26 2014 - 1 reports

Sedimentation Rate

A sedimentation rate is common blood test that is used to detect and monitor inflammation in the body. The sedimentation rate is also called the erythrocyte sedimentation rate because it is a measure of the speed that the red blood cells (erythrocytes) ... [Published eMedicine Health - Jun 26 2014]
First reported Jun 25 2014 - Updated Jun 25 2014 - 1 reports

Questcor Supports Myositis Awareness Day

September 21 events draw publicity for rare disease Contact InformationAvailable for logged-in reporters onlyFor interviews with TMA executive director or medical advisors, call TMA at 1-800-821-7356 or email TMA@myositis.org .Newswise — The Myositis ... [Published Newswise - Jun 25 2014]
First reported Apr 20 2014 - Updated Apr 20 2014 - 1 reports

Auto-Immune Self-Care Board?

Hi board community,I am posting in the autoimmune forum, because I am waiting for my initial visit with a rheumatologist. Lab work was: ANA 1,280, positive for rheumatoid factor, low level of c-reactive protein. Symptoms: Hand and wrist arthritis, swelling ... [Published HealthBoards - Apr 20 2014]
First reported Mar 13 2014 - Updated Mar 13 2014 - 3 reports

Idera Pharmaceuticals Announces Expansion of Pipeline into Two Orphan Autoimmune Diseases

CAMBRIDGE, Mass.--(EON: Enhanced Online News)--Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune disorders and genetically defined forms of B-cell ... [Published EON Science - Mar 13 2014]

Quotes

"In addition, our pilot effort focused on educating pulmonologists about Acthar in the treatment of respiratory manifestations of symptomatic sarcoidosis has generated a positive response over the last few months, consistent with our previous pilot detailing efforts in both nephrology and rheumatology. Prescribing activity by pulmonologists has exceeded our expectations since the pilot detailing effort began in February 2014, with approximately 40 to 45 new paid prescriptions shipped by pharmacies in the second quarter. As a result of these encouraging early results, we will be expanding the pulmonology sales force from 7 to 35 Acthar representatives and expect to complete this expansion by January 2015" concluded Mr. Cartt
"The present disclosure provides a method for treating a disease or disorder selected from the group consisting of pain (e g., acute pain, acute inflammatory pain, chronic inflammatory pain, and neuropathic pain), acute inflammation, chronic inflammation, rheumatoid arthritis, psoriasis, atopic dermatitis, asthma, bronchopulmonary dysplasia, COPD, adult respiratory disease, arthritis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, septic shock, endotoxic shock, gram negative sepsis, toxic shock syndrome, stroke, ischemia reperfusion injury, renal reperfusion injury, glomerulonephritis, thrombosis, Alzheimer's disease, graft vs. host reaction (i e., graft-versus-host disease), allograft rejections (e g., acute allograft rejection, and chronic allograft rejection), malaria, acute respiratory distress syndrome, delayed type hypersensitivity reaction, atherosclerosis, cerebral ischemia, cardiac ischemia, osteoarthritis, multiple sclerosis, restinosis, angiogenesis, angiogenesis associated with tumor growth, osteoporosis, gingivitis, respiratory viruses, herpes viruses, hepatitis viruses, HIV, Kaposi's sarcoma associated virus (i e., Kaposi's sarcoma), meningitis, cystic fibrosis, pre-term labor, cough, pruritis, multi-organ dysfunction, trauma, strains, sprains, contusions, psoriatic arthritis, herpes encephalitis, CNS vasculitis, traumatic brain injury, systemic tumors, CNS tumors, tumors dependent on angiogenesis for growth, leukopenia and neutropenia, chemotherapy-induced leukopenia and neutropenia, opportunistic infections associated with neutropenia or leukopenia, subarachnoid hemorrhage, post surgical trauma, interstitial pneumonitis, hypersensitivity, crystal induced arthritis, acute pancreatitis, chronic pancreatitis, acute alcoholic hepatitis, necrotizing enterocolitis, chronic sinusitis, angiogenic ocular disease, ocular inflammation, retinopathy of prematurity, diabetic retinopathy, macular degeneration with the wet type preferred, corneal neovascularization, polymyositis, vasculitis, acne, gastric ulcers, duodenal ulcers, celiac disease, esophagitis, glossitis, airflow obstruction, airway hyperresponsiveness (i e., airway hyperreactivity), bronchiectasis, bronchiolitis, bronchiolitis obliterans, chronic bronchitis, cor pulmonae, dyspnea, emphysema, hypercapnea, hyperinflation, hypoxemia, hyperoxia-induced inflammations, hypoxia, surgical lung volume reduction, pulmonary fibrosis, pulmonary hypertension, right ventricular hypertrophy, peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD), granulocytic ehrlichiosis, sarcoidosis, small airway disease, ventilation-perfusion mismatching, wheeze, colds, gout, alcoholic liver disease, lupus, burn therapy (i e., the treatment of burns), periodontitis, cancer, transplant reperfusion injury, and early transplantation rejection (e g., acute allograft rejection) in a patient in need of such treatment, comprising administering an effective amount of a compound of formula 1) or formula (2):"

More Content

All (25) | News (20) | Reports (0) | Blogs (5) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Questcor (QCOR) Misses on Q2 Earnings, Beats on... [Published Yahoo! Finance - Jul 25 2014]
Questcor Reports Record Second Quarter Financia... [Published Nasdaq - Jul 24 2014]
Bristol-Myers Squibb and Ono Pharmaceutical Co.... [Published Scottrade - Jul 24 2014]
Patent Issued for Aminopyridine- and Aminopyrim... [Published 4 Traders - Jul 24 2014]
Patients urged to 'partner' with caregivers [Published Fox 5 Atlanta WAGA - Jul 21 2014]
Neck pain, back pain, shoulder pain, arm… [Published Sachem Patch - Jul 10 2014]
Mason Smedley continues to inspire in partnersh... [Published Oregonian - Jul 09 2014]
Neck pain, back pain, shoulder pain, arm… [Published Five Towns Patch - Jul 03 2014]
Sedimentation Rate [Published eMedicine Health - Jun 26 2014]
Questcor Supports Myositis Awareness Day [Published Newswise - Jun 25 2014]
Auto-Immune Self-Care Board? [Published HealthBoards - Apr 20 2014]
Targeted transforming growth factor-beta-bound ... [Published PharmCast - Apr 17 2014]
Mallinckrodt to acquire Questcor Pharmaceutical... [Published PharmaBiz - Apr 08 2014]
Idera Pharmaceuticals announces expansion of pi... [Published Pharmaceutical Business Review - Mar 14 2014]
Idera Pharmaceuticals Announces Expansion of Pi... [Published EON Science - Mar 13 2014]
Idera Pharmaceuticals Announces Expansion of Pi... [Published Business Wire Science: Science News - Mar 13 2014]
Idera Pharmaceuticals Announces Expansion of Pi... [Published Business Wire Health News - Mar 13 2014]
Anyone knowledgeable about scleroderma? [Published HealthBoards - Mar 05 2014]
Delivery system for cytotoxic drugs by bispecif... [Published PharmCast - Mar 02 2014]
Tetrameric cytokines with improved biological a... [Published PharmCast - Dec 17 2013]
Inhibitors of antigen presentation by MHC class... [Published PharmCast - Dec 15 2013]
Dual variable domain immunoglobulins and uses t... [Published PharmCast - Dec 06 2013]
Engineered antibody constant domain molecules [Published PharmCast - Nov 26 2013]
US FDA submission for Tivicay combination [Published TrustNet - Oct 22 2013]
Process for identification of molecular mimicry... [Published PharmCast - Oct 04 2013]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Auto-Immune Self-Care Board? [Published HealthBoards - Apr 20 2014]
Hi board community,I am posting in the autoimmune forum, because I am waiting for my initial visit with a rheumatologist. Lab work was: ANA 1,280, positive for rheumatoid factor, low level of c-reactive protein. Symptoms: Hand and wrist arthritis, swelling ...
Idera Pharmaceuticals Announces Expansion of Pi... [Published EON Science - Mar 13 2014]
CAMBRIDGE, Mass.--(EON: Enhanced Online News)--Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune disorders and genetically defined forms of B-cell ...
Idera Pharmaceuticals Announces Expansion of Pi... [Published Business Wire Science: Science News - Mar 13 2014]
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune disorders and genetically defined forms of B-cell lymphoma, ...
Idera Pharmaceuticals Announces Expansion of Pi... [Published Business Wire Health News - Mar 13 2014]
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune disorders and genetically defined forms of B-cell lymphoma, ...
Anyone knowledgeable about scleroderma? [Published HealthBoards - Mar 05 2014]
Hi,I have been diagnosed with RA, Polymyositis, and Raynauds. While I am and have been so sick while taking the cellcept and prednisone, it is nothing compared to all the illnesses I have caught in my immune suppressed state. Not to mention the anxiety ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.